| Engineering vaccinia virus as an immunotherapeutic battleship to overcome tumor heterogeneity A Pelin, S Boulton, LA Tamming, JC Bell, R Singaravelu Expert opinion on biological therapy 20 (9), 1083-1097, 2020 | 22 | 2020 |
| DNA based vaccine expressing SARS-CoV-2 Spike-CD40L fusion protein confers protection against challenge in a Syrian hamster model LA Tamming, D Duque, A Tran, W Zhang, A Pfeifle, E Laryea, J Wu, ... Frontiers in Immunology 12, 785349, 2022 | 20 | 2022 |
| DNA lipid nanoparticle vaccine targeting outer surface protein C affords protection against homologous Borrelia burgdorferi needle challenge in mice A Pfeifle, SN Thulasi Raman, C Lansdell, W Zhang, L Tamming, ... Frontiers in Immunology 14, 1020134, 2023 | 16 | 2023 |
| Cellular and humoral immunogenicity of a candidate DNA vaccine expressing SARS-CoV-2 spike subunit 1 KA Alluhaybi, RH Alharbi, RY Alhabbab, ND Aljehani, SS Alamri, ... Vaccines 9 (8), 852, 2021 | 15 | 2021 |
| The expression kinetics and immunogenicity of lipid nanoparticles delivering plasmid DNA and mRNA in mice W Zhang, A Pfeifle, C Lansdell, G Frahm, J Cecillon, L Tamming, C Gravel, ... Vaccines 11 (10), 1580, 2023 | 13 | 2023 |
| Single immunization with recombinant ACAM2000 vaccinia viruses expressing the spike and the nucleocapsid proteins protects hamsters against SARS-CoV-2-caused clinical disease Y Deschambault, J Lynch, B Warner, K Tierney, D Huynh, R Vendramelli, ... Journal of Virology 96 (9), e00389-22, 2022 | 11 | 2022 |
| CRISPR-mediated rapid arming of poxvirus vectors enables facile generation of the novel immunotherapeutic STINGPOX JT Whelan, R Singaravelu, F Wang, A Pelin, LA Tamming, G Pugliese, ... Frontiers in Immunology 13, 1050250, 2023 | 7 | 2023 |
| Synthetic vaccine affords full protection to mice against lethal challenge of influenza B virus of both genetic lineages C Gravel, A Muralidharan, A Duran, A Zetner, A Pfeifle, W Zhang, ... Iscience 24 (11), 2021 | 7 | 2021 |
| Thulasi Raman, SN; Wang, L.; et al W Zhang, A Pfeifle, C Lansdell, G Frahm, J Cecillon, L Tamming, C Gravel, ... The Expression Kinetics and Immunogenicity of Lipid Nanoparticles Delivering …, 2023 | 5 | 2023 |
| DNA based vaccine expressing SARS-CoV-2 Spike-CD40L fusion protein confers protection against challenge in a Syrian hamster model. Front Immunol 12: 785349 LA Tamming, D Duque, A Tran, W Zhang, A Pfeifle, E Laryea, J Wu, ... | 5 | 2021 |
| Bivalent vaccines effectively protect mice against influenza A and respiratory syncytial viruses SNT Raman, A Zetner, AM Hashem, D Patel, J Wu, C Gravel, J Gao, ... Emerging Microbes & Infections 12 (1), 2192821, 2023 | 2 | 2023 |
| Dissecting immunological mechanisms underlying influenza viral nucleoprotein-induced mucosal immunity against diverse viral strains W Zhang, A Sloan, J Prévost, L Tamming, S Raman, A Pfeifle, C Gravel, ... Emerging Microbes & Infections 13 (1), 2427792, 2024 | 1 | 2024 |
| Lipid nanoparticle encapsulation of a Delta spike-CD40L DNA vaccine improves effectiveness against Omicron challenge in Syrian hamsters L Tamming, D Duque, A Tran, C Lansdell, G Frahm, J Wu, EEF Fekete, ... Molecular Therapy Methods & Clinical Development 32 (3), 2024 | 1 | 2024 |
| Metaproteomics reveals age-specific alterations of gut microbiome in hamsters with SARS-CoV-2 infection M Creskey, FS Angulo, Q Wu, L Tamming, E Fekete, K Cheng, Z Ning, ... bioRxiv, 2024.11. 12.623292, 2024 | 1 | 2024 |
| Lipid nanoparticle encapsulation of a Delta spike-CD40L DNA vaccine improves effectiveness Omicron in hamsters (vol 32, 101325, 2024) L Tamming, D Duque, J Bavananthasivam, A Tran, C Lansdell, G Frahm, ... MOLECULAR THERAPY METHODS & CLINICAL DEVELOPMENT 33 (1), 2025 | | 2025 |
| Mucosal SARS-CoV-2 S1 adenovirus-based vaccine elicits robust systemic and mucosal immunity and protects against disease in animals ND Aljehani, L Tamming, MY Khan, RH Abdulal, MA Alfaleh, A Ghazwani, ... mBio 16 (1), e02170-24, 2025 | | 2025 |
| Novel recombinant vaccinia virus-vectored vaccine affords complete protection against homologous Borrelia burgdorferi infection in mice A Pfeifle, W Zhang, J Cao, SN Thulasi Raman, R Anderson-Duvall, ... Emerging Microbes & Infections 13 (1), 2399949, 2024 | | 2024 |
| Lipid nanoparticle encapsulation enhances the immunogenicty of a SARS-CoV-2 Delta variant-based DNA vaccine and enables protection against heterologous omicron subvariants L Tamming, D Duque, C Lansdell, S Raman, L Wang, A Tran, M Johnston, ... The Journal of Immunology 212 (1_Supplement), 0117_5136-0117_5136, 2024 | | 2024 |
| A Modified Recombinant DNA‐Based SARS‐CoV‐2 Vaccine Expressing Stabilized Uncleavable Spike Protein Elicits Humoral and Cellular Immunity against Various SARS‐CoV‐2 Variants of … RH Abdulal, MY Khan, ND Aljehani, ZI Fallata, RH AlHarbi, ... Transboundary and Emerging Diseases 2023 (1), 5279979, 2023 | | 2023 |
